ArticleFrontiers in pharmacology2022

Integrative Pan-Cancer Analysis Confirmed that FCGR3A is a Candidate Biomarker Associated With Tumor Immunity.

Lilin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.